CAR-T Trial for JCAR017 Now Open at USCD and 27 Other Sites Across the USA An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma... October 5, 2019News about Clinical TrialsBy Brad Hedrick
The Transcend 004 Clinical Trial The Transcend CLL 004 Clinical Trial is looking for patients with relapsed or refractory CLL/SLL. The investigational treatment uses a... July 15, 2019News about Clinical TrialsBy Brad Hedrick
A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL offers an option of a novel agent... July 9, 2019News about Clinical TrialsBy Brad Hedrick
Two New Free Vaccine Trials at the NIH The National Institutes of Health were founded by Congress in 1887 and charged with being the preeminent research center in... April 9, 2019News about Clinical TrialsBy Brad Hedrick
Clinical Trials and our Clinical Trial Banner You may notice a new feature on the CLL Society website, a Clinical Trial Banner on our home page. As many... October 21, 2018News about Clinical TrialsBy Brad Hedrick
New trial for early stage high-risk CLL patients. The vast majority of patients (approximately 75%) with newly diagnosed CLL do not need treatment at the time of initial... October 12, 2018News about Clinical TrialsBy Brad Hedrick
Monoclonal B-cell Lymphocytosis Study Researchers at Queen’s University Belfast in the UK, are conducting the first large-scale survey of Monoclonal B-cell lymphocytosis patients and... March 16, 2018News about Clinical TrialsBy Todd Dennison
CAR-T trial for CLL (chronic lymphocytic leukemia) at City of Hope City of Hope is one of the leading centers for novel cellular therapies. Slots for a Juno CAR-T CLL trial... February 21, 2018News about Clinical TrialsBy Todd Dennison
A Clinical Trial for Chronic Lymphocytic Leukemia (CLL) Patients Intolerant of Prior Therapies While novel kinase inhibitor (KI) medications such as ibrutinib and idelalisib have revolutionized care for chronic lymphocytic leukemia (CLL), some... July 11, 2017News about Clinical TrialsBy Todd Dennison
A New Clinical Trial for Patients with Relapsed Refractory CLL Who Have Received 2 or more Prior Treatments, Including Treatment with a BTK Inhibitor such as Ibrutinib or Acalabrutinib PURPOSE OF THE STUDY: The purpose of the study is to test the investigational oral drug known as SNS-062, a... June 13, 2017News about Clinical TrialsBy Todd Dennison
